Concepedia

Elias Jabbour

EJ

4

Publications

220

Citations

4

H-Index

2014

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Cleveland Clinic

Fred Hutch Cancer Center

Elias Jabbour is an author at The University of Texas MD Anderson Cancer Center specializing in hematology, pharmacotherapy, and medicine.

Top concepts

Publications per year

2014–2024

4

Publications

4

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

Marina Konopleva, Peter F. Thall, Cecilia Arana Yi et al. · Haematologica · 2015 · 119 citations · Full text

, , +18

Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial

Elias Jabbour, Nicola Gökbuget, Anjali S. Advani et al. · Leukemia Research · 2019 · 50 citations · Full text

Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia

Naval Daver, Aditi Shastri, Tapan M. Kadia et al. · Leukemia Research · 2014 · 30 citations · Full text

, , +6

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

Elias Jabbour, Vivian G. Oehler, Paul Koller et al. · JAMA Oncology · 2024 · 21 citations · Full text

Rows per page

1–4 of 4